Mounjaro overdose: what actually happens and what to do

The biggest myth: a double dose just means faster results

This is the misconception our prescribers encounter more than any other in this area. The logic feels intuitive, if one dose reduces appetite and blood sugar, two doses do it twice as well. It doesn't work that way. Tirzepatide's effect is not linear at double the concentration; what scales up is the side-effect burden, not the therapeutic benefit.

The licensed starting dose of 2.5mg exists because the body needs time to adjust to the medicine's effects on gastric emptying and gut-hormone signalling. Jump ahead with an accidental repeat injection at that stage and you're not getting two weeks of results in one, you're more likely getting two weeks of nausea compressed into 48 hours, along with a real risk of dehydration if vomiting and diarrhoea follow. At higher maintenance doses the stakes are similar. How tirzepatide works in the body helps explain why doubling up doesn't amplify the benefit the way people assume.

The NHS and the Mounjaro patient information leaflet both make clear that if you use more than your prescribed dose, you should seek medical advice promptly. The medicine's SmPC, available on the electronic Medicines Compendium, describes supportive care as the appropriate clinical response, there is no reversal agent for tirzepatide.

What symptoms to watch for after accidental excess dosing

Most reported effects of tirzepatide overdose are extensions of its known side-effect profile, arriving harder and faster than at a normal therapeutic dose. Nausea is typically the first sign, often severe enough to prevent eating or drinking normally. Vomiting and diarrhoea may follow, and the real danger here is dehydration, which can put pressure on the kidneys if it continues for more than a few hours without fluid intake.

Low blood sugar is a specific concern for people who take other diabetes medicines alongside tirzepatide. Tirzepatide on its own has a low hypoglycaemia risk because its action is glucose-dependent, but in combination with sulfonylureas or insulin the risk rises. Symptoms of hypoglycaemia include shakiness, sweating, confusion, rapid heartbeat and, in serious cases, loss of consciousness. If any of those appear, call 999.

For people without diabetes, the main risks remain GI-led: significant vomiting, inability to keep fluids down, dizziness from dehydration. These aren't minor inconveniences at overdose scale, persistent vomiting over several hours in a person who can't rehydrate is a genuine medical situation. The NHS tirzepatide page lists the side effects associated with the medicine and flags which ones need prompt attention. Read it alongside this page, not instead of it.

What an overdose does not cause: tirzepatide has no reported cardiac toxicity, central nervous system depression or respiratory risk in published overdose data at doses close to the therapeutic range. That doesn't mean doing nothing is safe, it means the active danger is GI and metabolic, and those can escalate.

What to do right now if you've taken too much

First, don't panic, but do act. The steps below follow NHS guidance on accidental medicine overdose:

If you feel well and symptoms are mild (some extra nausea, no vomiting yet), call NHS 111. Have the pen, the box or the leaflet nearby so you can describe the strength and the approximate timing. A nurse or pharmacist will advise whether you need to be seen in person.

If you are vomiting repeatedly, cannot keep water down, feel faint or are experiencing symptoms of low blood sugar, call 999 or get to an emergency department. Again, bring the packaging. Clinicians need to know exactly which strength you used and when.

Do not try to eat a large meal to counteract it, if gastric emptying is severely slowed, eating may worsen nausea. Small sips of water are generally appropriate while waiting for medical advice.

Do not inject your next scheduled dose that week. Your prescriber will advise when to resume, based on how you recover. Separately, it's worth reading about what the period after a Mounjaro dose looks like in normal circumstances, so you have a clearer baseline for what's expected and what isn't.

Preventing it: storage, scheduling and the injection routine

Most accidental overdoses with tirzepatide happen for one of three reasons: a diary error (losing track of the injection day), using the wrong pen from a multi-strength set, or confusing a fresh pen with one already used. The KwikPen's locking mechanism (it clicks and the needle retracts after a complete dose) helps, but it isn't foolproof if someone is distracted or administering mid-rush.

Practical habits that reduce the risk: write the injection day on a calendar or set a phone reminder, not just a mental note. Keep pens in their original box so the strength is always visible, especially important if someone in the household uses a different dose. If you're new to the injection routine, our Mounjaro injection guide covers technique and common user errors in detail.

On the cost side, some patients ask about splitting doses or using leftover medicine from a previous strength to avoid running out, both are practices that carry overdose risk and are not sanctioned by the prescriber or the SmPC. The Mounjaro pricing page sets out what a full course costs privately, which is relevant context if supply management is part of why someone is improvising.

If food timing around your dose is adding to GI symptoms (a separate but related concern) what happens if you don't eat on Mounjaro addresses that in more detail. Getting the basics right reduces the chance of side effects that could be mistaken for something more serious.